Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2000 Dec;91(12):1333–1338. doi: 10.1111/j.1349-7006.2000.tb00922.x

Improved in vivo Antitumor Efficacy and Reduced Systemic Toxicity of Carboxymethylpullulan‐peptide‐doxorubicin Conjugates

Hideo Nogusa 1, Hiroshi Hamana 1, Naomi Uchida 1, Ryuji Maekawa 1, Takayuki Yoshioka 1,
PMCID: PMC5926308  PMID: 11123434

Abstract

The antitumor efficacy of the conjugate of doxorubicin (DXR) and carboxymethylpullulan (CMPul) with Phe‐Gly spacer (CMPul‐FG‐DXR) was evaluated using murine tumor models and compared with that of DXR. The conjugate exhibited higher antitumor efficacy against Lewis lung carcinoma than DXR. Complete tumor regression followed by long‐term tumor‐free survival was frequently observed when CMPul‐FG‐DXR was administered i.v. three times at a dose equivalent to 10 mg/kg of DXR. The superior survival as well as anti‐metastatic effect of CMPul‐FG‐DXR in comparison with DXR was also demonstrated with the M5076 murine reticulosarcoma model. Body weight loss in mice treated with the conjugate was less than that in the DXR‐treated group, indicating lower systemic toxicity of CMPul‐FG‐DXR. Simply mixing CMPul with DXR did not enhance the antitumor activity of DXR, showing that the conjugation of DXR with CMPul is necessary for improved antitumor activity. However, no enhanced antitumor efficacy of the conjugates was observed against a non‐solid tumor model such as P388 leukemia. In summary, improved antitumor efficacy with reduced systemic toxicity of CMPul‐FG‐DXR was demonstrated in the present study. CMPul‐FG‐DXR may be useful as a cancer chemotherapy agent against solid tumors and metastases.

Keywords: Carboxymethylpullulan, Doxorubicin, Polymeric drug, Enhanced permeability and retention

Full Text

The Full Text of this article is available as a PDF (67.8 KB).

REFERENCES

  • 1. ) Matsumura , Y. and Maeda , H.A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs . Cancer Res. , 46 , 6387 – 6392 ( 1986. ). [PubMed] [Google Scholar]
  • 2. ) Noguchi , Y. , Wu , J. , Duncan , R. , Strohalm , J. , Ulbrich , K. , Akaike , T. and Maeda , H.Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues . Jpn. J. Cancer Res. , 89 , 307 – 314 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Vasey , P. A. , Kaye , S. B. and Morrison , R.Phase I clinical and pharmacokinetic study of PK1: first member of a new class of chemotherapeutic agents‐drug‐polymer conjugates . Clin. Cancer Res. , 5 , 83 – 94 ( 1999. ). [PubMed] [Google Scholar]
  • 4. ) Nakamura , S.Pullulan . J. Synth. Org. Chem. Jpn. , 42 , 584 – 588 ( 1984. ) ( in Japanese ). [Google Scholar]
  • 5. ) Nogusa , H. , Yano , T. , Kajiki , M. , Gonsho , A. , Hamana , H. and Okuno , S.Antitumor effects and toxicities of carboxymethylpullulan‐peptide‐doxorubicin conjugates . Biol. Pharm. Bull. , 20 , 1061 – 1065 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Nogusa , H. , Yano , T. , Kajiki , M. , Gonsho , A. , Hamana , H. and Okuno , S.Structure‐activity relationships of carboxymethylpullulan‐peptide‐doxorubicin conjugates—systematic modification of peptide spacers . Bioorg. Med. Chem. Lett. , 10 , 227 – 230 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Nogusa , H. , Yamamoto , K. , Yano , T. , Kajiki , M. , Hamana , H. and Okuno , S.Distribution characteristics of carboxymethylpullulan‐peptide‐doxorubicin conjugates in tumorbearing rats: different sequence of peptide spacers and DXR contents . Biol. Pharm. Bull. , 23 , 621 – 626 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Nogusa , H. , Yano , T. , Okuno , S. , Hamana , H. and Inoue , K.Synthesis of carboxymethylpullulan‐peptide‐doxorubicin conjugates and their properties . Chem. Pharm. Bull. , 43 , 1931 – 1936 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Uchida , N. , Yoshida , H. , Yamada , H. , Wada , T. , Daikatsu , K. , Ikeuchi , I. , Maekawa , R. , Sugita , K. and Yoshioka , T.Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model . Jpn. J. Cancer Res. , 90 , 887 – 894 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Uchida , N. , Takeda , Y. , Hojo , K. , Maekawa , R. , Sugita , K. and Yoshioka , T.Sequence‐dependent antitumor efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5‐fluorouracil on in vivo murine tumor model . Eur. J. Cancer , 34 , 1796 – 1801 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Wallenstein , S. , Zucker , C. L. and Fleis , J. L.Some statistical methods useful in circulation research . Circ. Res. , 47 , 1 – 9 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Dunnett , C. W.New tables for multiple comparisons with a control . Biometrics , 20 , 482 – 491 ( 1964. ). [Google Scholar]
  • 13. ) Hart , I. R. , Talmadge , J. E. and Filder , I. J.Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ‐specific growth . Cancer Res. , 41 , 1281 – 1287 ( 1981. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES